Products 1919820-28-2

CAS 1919820-28-2 appears in our catalog under these names: Gcase activator 1/ 99.44% (existing batch purity), LTI–291, Pariceract, 99.11%, Gcase activator 1, 99%, 5,7-Dimethyl-N-(trans-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, 99%. Offered by: TargetMol, GLPBio, MedChemExpress, Ambeed, BLDpharm. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 500mg, 25 mg.

Gcase activator 1/ 99.44% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 7
from 452.11
View product
LTI–291
GLPBio
  • size: 10mg, 100mg, 25mg, 5mg
  • Variants: 5
from 854.47
View product
Pariceract, 99.11%
MedChemExpress
  • size: 25 mg, 10mM/1mL, 100 mg, 10 mg
  • Variants: 6
from 695.86
View product
Gcase activator 1, 99%
Ambeed
  • size: 250mg
  • Variants: 1
from 3023.69
View product
5,7-Dimethyl-N-(trans-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, 99%
BLDpharm
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 5
from 458.75
View product
5,7-Dimethyl-N-((1r,4r)-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, 99%
Chemat
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 7
from 150.80
View product
Structural formula: {0} (CAS {1})

5,7-dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (CAS 1919820-28-2) is a chemical compound with the molecular formula C20H30N4O2 and a molecular weight of 358.5 g/mol. IUPAC name: 5,7-dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide. InChIKey: HZILSILAELSWKN-UHFFFAOYSA-N.

Identity
Molecular formulaC20H30N4O2
Molecular weight358.5 g/mol
IUPAC name5,7-dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
InChIKeyHZILSILAELSWKN-UHFFFAOYSA-N
SMILESCCCCCOC1CCC(CC1)NC(=O)C2=C3N=C(C=C(N3N=C2)C)C

Computed by PubChem (NCBI)

Synonyms: Gcase activator 1, 5,7-Dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, Pariceract, pariceract [INN], orb1222565, orb1302992, s1024
Isomers (same molecular formula)
(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide C20H30N4O2
(2S)-2-[[(2S)-2-(2-cyanoethylamino)-3-methylbutanoyl]amino]-4-methyl-N-phenylpentanamide C20H30N4O2
(E)-3-[1-[2-(diethylamino)ethyl]-2-(2,2,3,3,4,4,4-heptadeuteriobutyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide C20H30N4O2